At Armida Labs we are developing innovative, integrated drug discovery technologies that change the face of chemotherapy. Armida Labs is a University of California Riverside spin off company founded by Professor Maurizio Pellecchia. Based on groundbreaking work conceived in the Pellecchia Lab, we are pioneering a new classes of antimetastatic targeted therapeutics. Our pipe line includes also targeted delivery of chemotherapy, and Lysine-covalent agents that fight cancer resistance.
